Investigation of pharmaceutical metabolites in environmental waters by LC-MS/MS

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Environmental science and pollution research international

• Publication date

  2014-01-10

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/s11356-013-2464-5PMID 24407783
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of new omeprazole metabolites in wastewaters and surface waters.

  2014cited by this paper
• Investigating the presence of omeprazole in waters by liquid chromatography coupled to low and high resolution mass spectrometry: degradation experiments.

  2013cited by this paper
• Importance of MS selectivity and chromatographic separation in LC-MS/MS-based methods when investigating pharmaceutical metabolites in water. Dipyrone as a case of study.

  2012cited by this paper
• Coupled chromatographic and mass-spectrometric techniques for the analysis of emerging pollutants in the aquatic environment

  2012cited by this paper
• Direct analysis of pharmaceuticals, their metabolites and transformation products in environmental waters using on-line TurboFlow™ chromatography-liquid chromatography-tandem mass spectrometry.

  2012cited by this paper
• Occurrence and distribution of multi-class pharmaceuticals and their active metabolites and transformation products in the Ebro river basin (NE Spain).

  2012cited by this paper
• Liquid chromatography coupled to tandem mass spectrometry for the residue determination of ethylenethiourea (ETU) and propylenethiourea (PTU) in water.

  2012cited by this paper
• Analysis of 100 pharmaceuticals and their degradates in water samples by liquid chromatography/quadrupole time-of-flight mass spectrometry.

  2012cited by this paper
• Tracing pharmaceuticals in a municipal plant for integrated wastewater and organic solid waste treatment.

  2012cited by this paper
• Multi-class determination of personal care products and pharmaceuticals in environmental and wastewater samples by ultra-high performance liquid-chromatography-tandem mass spectrometry.

  2012cited by this paper
• Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry.

  2012cited by this paper
• Hospital wastewater treatment by membrane bioreactor: performance and efficiency for organic micropollutant elimination.

  2012cited by this paper
• Input of selected human pharmaceutical metabolites into the Norwegian aquatic environment.

  2011cited by this paper
• Simultaneous determination of 15 top-prescribed pharmaceuticals and their metabolites in influent wastewater by reversed-phase liquid chromatography coupled to tandem mass spectrometry.

  2011cited by this paper
• Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk.

  2011cited by this paper
• Use of an accurate-mass database for the systematic identification of transformation products of organic contaminants in wastewater effluents.

  2011cited by this paper
• Retrospective LC-QTOF-MS analysis searching for pharmaceutical metabolites in urban wastewater.

  2011cited by this paper
• Multi-class determination of around 50 pharmaceuticals, including 26 antibiotics, in environmental and wastewater samples by ultra-high performance liquid chromatography-tandem mass spectrometry.

  2011cited by this paper
• Simultaneous determination of acidic, neutral and basic pharmaceuticals in urban wastewater by ultra high-pressure liquid chromatography-tandem mass spectrometry.

  2010cited by this paper
• Pollution by psychoactive pharmaceuticals in the Rivers of Madrid metropolitan area (Spain).

  2010cited by this paper
• Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation.

  2010cited by this paper
• Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.

  2009cited by this paper
• Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water.

  2009cited by this paper
• Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS.

  2008cited by this paper
• Photodegradation study of three dipyrone metabolites in various water systems: identification and toxicity of their photodegradation products.

  2008cited by this paper
• Human pharmaceuticals in the aquatic environment: a challenge to Green Chemistry.

  2007cited by this paper
• Multi-residue method for the determination of basic/neutral pharmaceuticals and illicit drugs in surface water by solid-phase extraction and ultra performance liquid chromatography-positive electrospray ionisation tandem mass spectrometry.

  2007cited by this paper
• Human Pharmaceuticals in the Aquatic Environment: A Challenge to Green Chemistry

  2007cited by this paper
• Application of liquid chromatography/quadrupole-linear Ion trap mass spectrometry and time-of-flight mass spectrometry to the determination of pharmaceuticals and related contaminants in wastewater.

  2007cited by this paper
• Excretion and ecotoxicity of pharmaceutical and personal care products in the environment.

  2006cited by this paper
• Degradation of lansoprazole and omeprazole in the aquatic environment.

  2006cited by this paper
• Determination of carbamazepine and its metabolites in aqueous samples using liquid chromatography-electrospray tandem mass spectrometry.

  2003cited by this paper
• Tandem mass spectrometry.

  1993cited by this paper

• Prevalence of illicit drugs and pharmaceuticals in environmental waters – A global spatial review

  2026cites this paper
• A category approach to characterize river sites based on non-target screening and target analysis

  2025cites this paper
• Untargeted metabolic profiling of Zygophyllum Coccineum plant near the Red Sea for phytochemical investigation by GC-MS, LC-MS, and NMR

  2025cites this paper
• Accurate determination of fluoxetine and its metabolites in Mediterranean mussel organs based on solid phase extraction clean-up and HPLC-HRMS.

  2025cites this paper
• Distribution and fate of antibiotics and their main metabolites in sludge stabilization technologies.

  2025cites this paper
• DEVELOPMENT OF SOLID PHASE EXTRACTION METHOD FOR THE LC-PDA DETECTION OF SELECTED PHARMACEUTICALS AND THEIR METABOLITES IN SURFACE WATER AND SEDIMENT FROM THE ISIPINGO RIVER, KZN, SOUTH AFRICA

  2025cites this paper
• Magnetic nanocellulose for losartan removal: Adsorption and ecotoxicity assessment.

  2025cites this paper
• Bibliometric analysis of emerging contaminants and cytostatic compounds: understanding the current challenges

  2024cites this paper
• Oxidative degradation by Fenton's Method for ten pharmaceutical drugs largely used in a Brazilian City

  2024cites this paper
• Fate of pharmaceutical residue in two Romanian rivers receiving treated water: Occurrence, distribution and risk assessment.

  2024cites this paper
• Hydroxylated transformation products of pharmaceutical active compounds: Generation from processes used in wastewater treatment plants and its environmental monitoring.

  2023cites this paper
• Evaluation of direct sample injection as a fast, no-sample handling, approach for the LC-MS/MS monitoring of pharmaceuticals in different water matrices

  2023cites this paper
• Multiclass target analysis of contaminants of emerging concern including transformation products, soil bioavailability assessment and retrospective screening as tools to evaluate risks associated with reclaimed water reuse.

  2022cites this paper
• Sartan blood pressure regulators in classical and biofilm wastewater treatment - Concentrations and metabolism.

  2022cites this paper
• Monitoring the exposure and emissions of antibiotic resistance: Co-occurrence of antibiotics and resistance genes in wastewater treatment plants.

  2022cites this paper
• ECOTOXICITY OF LOSARTAN POTASSIUM IN AQUATIC ORGANISMS OF DIFFERENT TROPHIC LEVELS.

  2021cites this paper
• Analysis and occurrence of macrolide residues in stream sediments and underlying alluvial aquifer downstream from a pharmaceutical plant.

  2021cites this paper
• Interaction of pharmaceutical metabolites with blood proteins and membrane lipids in the view of bioconcentration: A preliminary study based on in vitro assessment.

  2021cites this paper
• Occurrence of pharmaceutical metabolites and transformation products in the aquatic environment of the Mediterranean area

  2021influential citation
• Transformation products of pharmaceuticals in the environment: Their fate, (eco)toxicity and bioaccumulation potential.

  2021cites this paper
• Comprehensive Characterization of 76 Pharmaceuticals and Metabolites in Wastewater by LC-MS/MS

  2021cites this paper
• Removal efficiency for emerging contaminants in a WWTP from Madrid (Spain) after secondary and tertiary treatment and environmental impact on the Manzanares River.

  2021cites this paper
• Occurrence and ecological risks of pharmaceuticals in a Mediterranean river in Eastern Spain.

  2020cites this paper
• Investigation of pharmaceuticals and their metabolites in Brazilian hospital wastewater by LC-QTOF MS screening combined with a preliminary exposure and in silico risk assessment.

  2020cites this paper
• Routine analytical method for monitoring the main metabolites for a recurrent group of parabens and pharmaceuticals in wastewater and tap water

  2019cites this paper
• Main strategies, analytical trends and challenges in LC-MS and ambient mass spectrometry–based metabolomics

  2018cites this paper
• 'An investigation into the occurrence and removal of pharmaceuticals in Colombian wastewater'.

  2018cites this paper
• Development of a robust extraction procedure for the HPLC-ESI-HRPS determination of multi-residual pharmaceuticals in biota samples.

  2018cites this paper
• Modeling of Sorption and Degradation of selected Pharmaceuticals: case study of Belgrade Groundwater Source - Well Rb-16

  2017cites this paper
• Comprehensive determination of macrolide antibiotics, their synthesis intermediates and transformation products in wastewater effluents and ambient waters by liquid chromatography-tandem mass spectrometry.

  2017cites this paper
• Photochemical transformation and wastewater fate and occurrence of omeprazole: HRMS for elucidation of transformation products and target and suspect screening analysis in wastewaters.

  2017cites this paper
• UHPLC-QTOF MS screening of pharmaceuticals and their metabolites in treated wastewater samples from Athens.

  2017cites this paper
• Analysis, occurrence, fate and risks of proton pump inhibitors, their metabolites and transformation products in aquatic environment: A review.

  2016influential citation
• Occurrence and behavior of selected pharmaceuticals during riverbank filtration in The Republic of Serbia

  2016cites this paper
• High resolution mass spectrometry to investigate omeprazole and venlafaxine metabolites in wastewater.

  2016cites this paper
• Multiresidue trace analysis of pharmaceuticals, their human metabolites and transformation products by fully automated on-line solid-phase extraction-liquid chromatography-tandem mass spectrometry.

  2016cites this paper
• A review of the fate of micropollutants in wastewater treatment plants

  2015cites this paper
• Matrix effects in human urine analysis using multi-targeted liquid chromatography-tandem mass spectrometry.

  2015cites this paper